Edwards Lifesciences Corporatio vs GE HealthCare Technologies Inc.
A head-to-head of Edwards Lifesciences Corporatio (EW) and GE HealthCare Technologies Inc. (GEHC) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | EW | GEHC |
|---|---|---|
| Market Cap | $49.52B | $28.22B |
| P/E (TTM) | 46.99 | 14.84 |
| Forward P/E | 24.20 | 11.18 |
| P/S | 7.43 | 1.32 |
| P/B | 4.83 | 2.61 |
| EV/EBITDA | 23.06 | 10.08 |
| Dividend Yield | — | 0.22% |
| Profit Margin | 17.34% | 9.10% |
| Gross Margin | 78.01% | 39.99% |
| Operating Margin | 26.97% | 13.39% |
| Revenue Growth (YoY) | +16.70% | +7.41% |
| FCF Yield | 2.85% | 5.49% |
| Debt / Equity | 5.79 | 92.99 |
| Current Ratio | 3.72 | 1.22 |
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.